AnalystBook Research · Company Intelligence

CARDINAL HEALTH INC

CAHNYSE

Built from CARDINAL HEALTH INC's own SEC filings · updates as new filings land · sources cited throughout

or browse all covered companies

CARDINAL HEALTH INC: Revenue declined 1.9% to $223B from $227B. Net income grew 83.2% to $1.561B from $852M. Free cash flow declined 43.1% to $1.85B from $3.251B. Operating margin expanded 47 bps to 1.02%. CARDINAL HEALTH INC's annual comparison also shows margins improved while free cash flow declined; stock compensation grew faster than revenue; capital spending grew faster than revenue; inventory grew faster than revenue.

The read at a glance✓ Audited against SEC data
  • GrowthRevenue declined 1.9% to $223B from $227BWatch
  • ProfitabilityNet income grew 83.2% to $1.561B from $852MOK
  • Cash flowFree cash flow declined 43.1% to $1.85B from $3.251BWatch
  • MarginsOperating margin expanded 47 bps to 1.02%OK
  • AccountingNo overriding statistical warningNote
  • Insiders0 purchases and 12 salesWatch

Business

Other Information Certain Commercial Practices Although our agreements with manufacturers sometimes require us to maintain inventory levels within specified ranges, our distribution businesses are generally not required by our customers to maintain particular inventory levels other than as needed to meet service level requirements.

Where the revenue comes from

Fiscal 2026, as CARDINAL HEALTH INC reports it. History and quarterly detail are in the app.

  • Pharmaceutical and Specialty Solutions$234.8B
  • GMPD$12.7B
  • Other Operating$6.8B

Leadership changes

From CARDINAL HEALTH INC's own filings, the day they're filed.

  • Anita Zielinski · Chief Accounting Officer · appointmenteff. 2026-11-05
  • Mary Scherer · Chief Accounting Officer · appointmenteff. 2026-11-05
  • Sudhakar Ramakrishna · Directors · departureeff. 2025-03-07

Latest filings

  • 8-K · Company announcement2026-08-11
  • 8-K · Company announcement2026-08-11
  • 10-K · Annual report2026-08-11
  • 8-K · Company announcement2026-08-05
  • 8-K · Company announcement2026-04-30
In the full recordFree for 14 days
  • What changed🔒
  • Insider signal🔒
  • Growth quality🔒
  • Margins & accounting🔒
  • Capital allocation🔒
  • Real risks🔒
  • The long arc🔒
  • Company history🔒
  • The filings, readable — with what changed vs the prior year highlighted🔒
  • Full financial statements, industry-aware, sources cited throughout🔒
  • Forensic score history & components — the trend, not one year🔒
  • Ownership: insider buys/sells, clusters, activist stakes🔒
  • Ana — ask about CARDINAL HEALTH INC, every answer cited to the official filings🔒

Every figure comes from the company's filings, and analysis whose figures don't match SEC data is rejected before publication.

14-day free trial, no credit card. For research purposes only; not investment advice.